Login / Signup

Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled Study.

Suha AbushammaTed WalkerKevin GarzaLing ChenDarren NixChien-Huan Chen
Published in: Crohn's & colitis 360 (2023)
Registered with ClinicalTrials.gov, NCT05340764.
Keyphrases
  • end stage renal disease
  • low dose
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • randomized controlled trial
  • peritoneal dialysis
  • open label
  • clinical trial
  • double blind
  • placebo controlled